Serotonin receptor 5-HT2A as a potential target for HCC immunotherapy

Serotonin receptor 5-HT2A as a potential target for HCC immunotherapy

Background While recent clinical trials of combination immunotherapies for hepatocellular carcinoma (HCC) have shown promising clinical efficacy and survival improvements breakthroughs, there is still much room for further improvement. A key limiting factor for HCC immunotherapy is the intrinsic imm...

Full description

Saved in:
Bibliographic Details
Main Authors: Han Chong Toh, Olaf Rotzschke, Yi Wen Tan, Nicholas Da Zhi Ang, Wendy Lee, Ser Mei Koh, Rong En Tay, Charmaine Min Ho, Hui Chien Tay, Daniel Z Lopez, Qiao Rui Na, Kim Peng Tan, Jackwee Lim, Maichan Lau, Laurent Rénia
Format: Article
Language:English
Published: BMJ Publishing Group 2025-06-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/13/6/e011088.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://jitc.bmj.com/content/13/6/e011088.full

Similar Items